Conflict — Mychoice: Testing an Interactive mHealth Tool
Citation(s)
Adderley-Kelly B, Green PM Strategies for successful conduct of research with low-income African American populations. Nurs Outlook. 2005 May-Jun;53(3):147-52. Review.
Barr PJ, Thompson R, Walsh T, Grande SW, Ozanne EM, Elwyn G Correction: the psychometric properties of CollaboRATE: a fast and frugal patient-reported measure of the shared decision-making process. J Med Internet Res. 2015 Feb 6;17(2):e32. doi: 10.2196/jmir.4272.
Comis R, Crowley J Baseline study of patient accrual onto publically sponsored U.S. cancer clinical trials: an analysis conducted for the global access project of the national patient advocate foundation, 2006.
Evelyn B, Toigo T, Banks D, Pohl D, Gray K, Robins B, Ernat J Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999. J Natl Med Assoc. 2001 Dec;93(12 Suppl):18S-24S. Review.
Gadegbeku CA, Stillman PK, Huffman MD, Jackson JS, Kusek JW, Jamerson KA Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension. Contemp Clin Trials. 2008 Nov;29(6):837-42. doi: 10.1016/j.cct.2008.06.001. Epub 2008 Jun 27.
Goldberg D The case for Eliminating Disparities in Clinical Trials. J Cancer Educ. 2009;24(2 Suppl):S34-8. doi: 10.1080/08858190903400484.
Gross CP Racial disparities in clinical trial enrolment. Lancet. 2008 Nov 15;372(9651):1713-4. doi: 10.1016/S0140-6736(08)61714-6.
Gul RB, Ali PA Clinical trials: the challenge of recruitment and retention of participants. J Clin Nurs. 2010 Jan;19(1-2):227-33. doi: 10.1111/j.1365-2702.2009.03041.x.
Hoerger M, Chapman BP, Mohile SG, Duberstein PR Development and psychometric evaluation of the Decisional Engagement Scale (DES-10): A patient-reported psychosocial survey for quality cancer care. Psychol Assess. 2016 Sep;28(9):1087-100. doi: 10.1037/pas0000294.
Knobf MT, Juarez G, Lee SY, Sun V, Sun Y, Haozous E Challenges and strategies in recruitment of ethnically diverse populations for cancer nursing research. Oncol Nurs Forum. 2007 Nov;34(6):1187-94. Review.
Kriston L, Scholl I, Hölzel L, Simon D, Loh A, Härter M The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ Couns. 2010 Jul;80(1):94-9. doi: 10.1016/j.pec.2009.09.034. Epub 2009 Oct 30.
Markman M, Petersen J, Montgomery R An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials. J Cancer Res Clin Oncol. 2008 Jan;134(1):115-8. Epub 2007 Jun 28.
Michaels, M S., S; ENACCT and Community-Campus Partnerships for Health, Communities as Partners in Cancer Clinical Trials: Changing Research, Practice and Policy. 2008: Silver Springs, MD.
Morris NS, MacLean CD, Chew LD, Littenberg B The Single Item Literacy Screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pract. 2006 Mar 24;7:21.
Newman LA, Roff NK, Weinberg AD Cancer clinical trials accrual: missed opportunities to address disparities and missed opportunities to improve outcomes for all. Ann Surg Oncol. 2008 Jul;15(7):1818-9. doi: 10.1245/s10434-008-9869-2. Epub 2008 Apr 19.
O'Connor AM Validation of a decisional conflict scale. Med Decis Making. 1995 Jan-Mar;15(1):25-30.
Rivera-Goba MV, Dominguez DC, Stoll P, Grady C, Ramos C, Mican JM Exploring decision-making of HIV-infected Hispanics and African Americans participating in clinical trials. J Assoc Nurses AIDS Care. 2011 Jul-Aug;22(4):295-306. doi: 10.1016/j.jana.2010.10.007. Epub 2011 Jan 21.
Schmotzer GL Barriers and facilitators to participation of minorities in clinical trials. Ethn Dis. 2012 Spring;22(2):226-30. Review.
Shavers VL, Lynch CF, Burmeister LF Factors that influence African-Americans' willingness to participate in medical research studies. Cancer. 2001 Jan 1;91(1 Suppl):233-6. Erratum in: Cancer 2001 Mar 15;91(6):1187.
Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007 Dec;14(12):3328-34. Epub 2007 Aug 8.
Symonds RP, Lord K, Mitchell AJ, Raghavan D Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines. Br J Cancer. 2012 Sep 25;107(7):1017-21. doi: 10.1038/bjc.2012.240. Epub 2012 May 31. Review.
Todd AM, Laird BJ, Boyle D, Boyd AC, Colvin LA, Fallon MT A systematic review examining the literature on attitudes of patients with advanced cancer toward research. J Pain Symptom Manage. 2009 Jun;37(6):1078-85. doi: 10.1016/j.jpainsymman.2008.07.009. Epub 2009 May 5. Review.
Weinberg, A D. Eliminating Disparities in Clinical Trials. cited 2009 June 4th, 2009; Version 2: Available from: http://www.bcm.edu/edict/home.html.
Mychoice: Testing an Interactive mHealth Tool to Enhance Communication and Informed Decision Making About Clinical Trial Participation in Cancer Patients
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
